Could a High-Fiber diet boost immunotherapy in breast cancer?
NCT ID NCT07311083
First seen Jan 05, 2026 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This study looks at whether women with triple-negative breast cancer can stick to a high-fiber, gut-healthy diet while undergoing immunotherapy and chemotherapy. Sixty participants will either join an online program with nutrition and mind-body support or receive a simple dietary flyer. The main goal is to see if the diet plan is feasible, not yet to measure cancer outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Evang. Kliniken Essen-Mitte gGmbH
RECRUITINGEssen, North Rhine-Westphalia, 45276, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
high-fiber diet (20-30 g/day) with fermented foods
What this could lead to
If successful, this could show that a high-fiber diet is doable for patients and may improve how well immunotherapy works, leading to a larger study on cancer remission.
What could go wrong
This is a small, early feasibility study with only 60 participants. It does not directly test if the diet improves cancer outcomes, so results may not lead to a proven treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.